Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in burkina faso, west africa

Clinical Microbiology and Infection

Volumn 19, Issue 12, 2013, Pages

  Kania, D ^a,b,c   Bekale A M ^a   Nagot, N ^b,c,d   Mondain, A M ^d   Ottomani, L ^d   Meda, N ^a   Traore M ^e   Ouedraogo J B ^a   Ducos, J ^b,c,d   Van de Perre, P ^b,c,d   Tuaillon, E ^b,c,d  

^a CENTRE MURAZ   (Burkina Faso)

^b INSERM   (France)

^c UNIV MONTPELLIER   (France)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

^e Centre d'Accueil de Dépistage et d'Information sur le SIDA CADI   (Burkina Faso)

Author keywords

Africa; Dried blood spot; hepatitis B virus; hepatitis C virus; human immunodeficiency virus; Screening strategy

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST; DRIED BLOOD SPOT TESTING; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; POINT OF CARE TESTING; PRIORITY JOURNAL; RAPID TEST; SEROLOGY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

AFRICA; DRIED BLOOD SPOT; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; SCREENING STRATEGY;

AIDS SERODIAGNOSIS; BURKINA FASO; CROSS-SECTIONAL STUDIES; DRIED BLOOD SPOT TESTING; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; PILOT PROJECTS; POINT-OF-CARE SYSTEMS; POVERTY;

EID: 84888036310     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12292     Document Type: Article

References (29)

1. Dalal S, Lee CW, Farirai T et al. Provider-initiated HIV testing and counseling: increased uptake in two public community health centers in South Africa and implications for scale-up. PLoS One 2011; 6: e27293.
2. Sweat M, Morin S, Celentano D et al. Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infect Dis 2011; 11: 525-532.
3. ONUSIDA. Rapport ONUSIDA sur l'épidemie mondiale de SIDA. Available at: www.unaids.org/globalreport/Global_report_fr.htm. Rapport Mondial 2010.
4. Collenberg E, Ouedraogo T, Ganame J et al. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: a comparative analysis. J Med Virol 2006; 78: 683-692.
5. Kania D, Sangare L, Sakande J et al. A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso. Transfusion 2009; 49: 2237-2240.
6. Simpore J, Granato M, Santarelli R et al. Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso. J Clin Virol 2004; 31: 78-80.
7. Rosenberg NE, Kamanga G, Phiri S et al. Detection of acute HIV infection: a field evaluation of the determine(R) HIV-1/2 Ag/Ab combo test. J Infect Dis 2011; 205: 528-534.
8. Pant Pai N, Balram B, Shivkumar S et al. Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 373-380.
9. Barin F, Plantier JC, Brand D et al. Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic. J Med Virol 2006; 78 (suppl 1): S13-S18.
10. Lofgren SM, Morrissey AB, Chevallier CC et al. Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities. AIDS 2009; 23: 2459-2466.
11. Marconi A, Balestrieri M, Comastri G et al. Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens. Clin Microbiol Infect 2009; 15: 93-97.
12. Plantier JC, Dachraoui R, Lemee V et al. HIV-1 resistance genotyping on dried serum spots. AIDS 2005; 19: 391-397.
13. Viljoen J, Gampini S, Danaviah S et al. Dried blood spot HIV-1 RNA quantification using open real-time systems in South Africa and Burkina Faso. J Acquir Immune Defic Syndr 2010; 55: 290-298.
14. Tappin DM, Greer K, Cameron S, Kennedy R, Brown AJ, Girdwood RW. Maternal antibody to hepatitis B core antigen detected in dried neonatal blood spot samples. Epidemiol Infect 1998; 121: 387-390.
15. Tuaillon E, Mondain AM, Meroueh F et al. Dried blood spot for hepatitis C virus serology and molecular testing. Hepatology 2010; 51: 752-758.
16. Kania D, Fao P, Valea D et al. Low prevalence rate of indeterminate serological human immunodeficiency virus results among pregnant women from Burkina Faso (West Africa). J Clin Microbiol 2010; 48: 1333-1336.
17. Matemo D, Kinuthia J, John F et al. Indeterminate rapid HIV-1 test results among antenatal and postnatal mothers. Int J STD AIDS 2009; 20: 790-792.
18. Branson BM. The future of HIV testing. J Acquir Immune Defic Syndr 2010; 55 (suppl 2): S102-S105.
19. Lakshmi V, Sudha T, Bhanurekha M, Dandona L. Evaluation of the Murex HIV Ag/Ab Combination assay when used with dried blood spots. Clin Microbiol Infect 2007; 13: 1134-1136.
20. Beelaert G, Vercauteren G, Fransen K et al. Comparative evaluation of eight commercial enzyme linked immunosorbent assays and 14 simple assays for detection of antibodies to HIV. J Virol Methods 2002; 105: 197-206.
21. Villar LM, de Oliveira JC, Cruz HM, Yoshida CF, Lampe E, Lewis-Ximenez LL. Assessment of dried blood spot samples as a simple method for detection of hepatitis B virus markers. J Med Virol 2011; 83: 1522-1529.
22. Chan HL, Wong VW, Wong GL, Tse CH, Chan HY, Sung JJ. A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B. Hepatology 2010; 52: 1232-1241.
23. Tuaillon E, Lozano C, Kuster N et al. Long-term hepatitis B virus surface antigen decay in HIV-1/hepatitis B virus-coinfected adults initiating a tenofovir-containing regimen. J Clin Microbiol 2012; 50: 3096-3098.
24. Tuaillon E, Mondain AM, Nagot N et al. Comparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes. PLoS One 2012; 7: e32143.
25. Li A, Yuan Q, Huang Z et al. Novel double-antigen sandwich immunoassay for human hepatitis B core antibody. Clin Vaccine Immunol 2010; 17: 464-469.
26. Croom HA, Richards KM, Best SJ et al. Commercial enzyme immunoassay adapted for the detection of antibodies to hepatitis C virus in dried blood spots. J Clin Virol 2006; 36: 68-71.
27. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
28. Seidenberg P, Nicholson S, Schaefer M et al. Early infant diagnosis of HIV infection in Zambia through mobile phone texting of blood test results. Bull World Health Organ 2012; 90: 348-356.
29. Siedner MJ, Haberer JE, Bwana MB, Ware NC, Bangsberg DR. High acceptability for cell phone text messages to improve communication of laboratory results with HIV-infected patients in rural Uganda: a cross-sectional survey study. BMC Med Inform Decis Mak 2012; 12: 56.